PMP, Off-Patent Drug Rules to Be Major Topics for 2024 Reform: MHLW Pharma Management Director

January 12, 2023
Takashi Yasukawa, Pharmaceutical Management Director, Medical Economics Division, Health Insurance Bureau, MHLW The review of the price maintenance premium (PMP) for innovative medicines and rules related to off-patent long-listed products (LLPs) will be the focus of the next drug pricing...read more